Previous Article | Next Article ![]()
Journal of Bacteriology, March 2003, p. 1582-1589, Vol. 185, No. 5
0021-9193/03/$08.00+0 DOI: 10.1128/JB.185.5.1582-1589.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Departments of Microbiology,1 Biochemistry, University of Illinois, Urbana, Illinois 618012
Received 10 October 2002/ Accepted 3 December 2002
|
|
|---|
|
|
|---|
![]() View larger version (18K): [in a new window] |
FIG. 1. Current models of lipoate attachment and synthesis. (A) Lipoate ligase reaction that utilizes exogenous sources of lipoic acid and octanoic acid. (B) Current model of lipoic acid synthesis and attachment. The sulfur insertion step is catalyzed by LipA. LipB then transfers the lipoate moiety from lipoyl-ACP to the lipoyl domains. However, an additional pathway is not precluded in which LipB transfers octanoate from ACP to the lipoyl domain to form the octanoyl-domain, which is recognized as a substrate for LipA-catalyzed sulfur insertion.
|
The physiological function of lipoic acid is dependent upon covalent attachment to specific lysine residues of the cognate enzymes. These specific lysine residues are found on protein domains called lipoyl domains that have conserved structures and sequences. These domains are found at the N terminus of a subunit of each of the lipoate-dependent enzymes (15). In E. coli there are two independent enzyme systems that modify lipoyl domains (12) (Fig. 1). Both enzymes can attach either lipoic acid or octanoic acid (the direct precursor of lipoic acid) to lipoyl domains. The best-characterized lipoylating enzyme is E. coli lipoate-protein ligase (LplA). LplA utilizes exogenously supplied free lipoic acid to modify the specific lysine of the lipoyl domain. LplA utilizes ATP to activate lipoic acid to lipoyl-AMP (Fig. 1). LplA then catalyzes the attack of enzyme-bound lipoyl-AMP by the
-amino group of the lysine of the lipoyl domain to give an amide linkage (Fig. 1). LplA has been shown to be required for E. coli to utilize lipoic acid from the environment (11). However, null mutants of lplA can be made without creating a deficiency of lipoylated enzymes due to the presence of a second LplA-independent lipoylation pathway (12). This second pathway is dependent on lipB (12) and involves a novel enzyme, lipoyl-[acyl carrier protein]-protein N-lipoyltransferase (8) that uses the lipoyl thioester of the acyl carrier protein (ACP) of fatty acid synthesis as the acyl donor and also functions with octanoyl-ACP (8). Strains carrying lipB mutations lack lipoyltransferase and thus the most straightforward hypothesis was that lipB encodes the enzyme. However, the data could also be explained by LipB acting as a positive regulator required for lipoyltransferase expression or activity. Despite a major effort we were unable to either prove or disprove that lipB encoded lipoyltransferase by purifying the enzyme to homogeneity since E. coli extracts contain extremely low levels of the protein (see below). Other workers (16, 22) have reported that lipB plays a role in the regulation of dam-encoded deoxyadenosine methylase (which in turn regulates a large variety of key cell processes), and thus it was necessary to resolve the function of LipB. We report genetic and biochemical evidence demonstrating that lipB encodes the lipoyl-[ACP]:protein N-lipoyltransferase (which is also an octanoyl-[ACP]:protein N-octanoyltransferase). We also show consistent with prior genetic data that the transfer of lipoic acid and octanoic acid from their ACP thioesters to lipoyl domains can also be catalyzed, albeit very poorly, by LplA.
|
|
|---|
Isolation of temperature-sensitive lipB mutants. Plasmid pKR111, which contains the complete lipB gene plus 127 bp of upstream sequence in a high-copy-number plasmid, was mutagenized with hydroxylamine for various time periods according to the protocol of Miller (10). A hydroxylamine treatment time yielding a 50% reduction in the number of ampicillin-resistant transformants was chosen. The hydroxylamine-treated plasmid preparations were then transformed into the lipB::Tn1000dKan lplA::Tn10 strain TM136, and the transformants were plated on glucose minimal E medium containing sodium ampicillin (100 µg/ml), tetracycline hydrochloride (15 µg/ml), and kanamycin sulfate (50 µg/ml), followed by incubation of the plates at 30°C for 2 days. Eight hundred of the resulting colonies were then tested on glucose-minimal plates containing ampicillin incubated at 30, 37, or 42°C. A parallel set of plates containing 5 ng of lipoate/ml was also prepared and was incubated at 37 or 42°C for 2 days. Three isolates were found that grew at 30°C without lipoate but which failed to grow at 37 or 42°C unless supplemented with lipoate. The plasmids from these strains were designated pSJ65, pSJ67, and pSJ68, and their lipB genes, together with that of the parental plasmid pKR111, were sequenced by the Keck Genomics Center of the University of Illinois.
Construction of a plasmid encoding a hexahistidine (His)-tagged LipB. Two plasmids were constructed, each of which contained an NcoI site overlapping the lipB initiation codon to be tested. Plasmid pSJ118, which encoded a gene beginning with the previously assigned ATG initiation codon, was produced by PCR amplification from plasmid pCTV616 with the primer LIPBATG (5'-CCCCCATGGATGAATTCACCGATACCCGCCATG-3') and primer LIPBSTOP (5'-CCCAAGCTTAAGGGGTAATATATTCGAAGTC-3'). The PCR product was cloned into plasmid pCR2.1 by using the TA cloning kit (Invitrogen) to produce plasmid pSJ118. Plasmid pSJ112 resulted from the same manipulations except that primer LIPBTTG (5'-CCCCCATGGATCAGGATAAAATTCTTGTC-3') was used as the upstream primer and the encoded gene started at the TTG codon (which was changed to ATG in making the NcoI site). The NcoI-HindIII lipB fragments of plasmids pSJ112 and pSJ118 were ligated to vector pKK233-2 (Pharmacia) cut with the same enzymes to yield plasmids pSJ115 and pSJ119, respectively. The same manipulations, except that vector pET30(a) (Novagen) was used in place of vector pKK233-2, yielded plasmids pSJ120 and pSJ122 derived from plasmids pSJ112 and pSJ118, respectively.
Purification and assay of LipB and LplA. His-tagged LipB was purified by using Qiagen immobilized nickel-agarose matrix according to the protocol supplied by Qiagen. His-tagged LipB was then further purified by chromatography on a Mono-Q anion-exchange column (Pharmacia). The sample was adsorbed to the Mono-Q column by using 50 mM Tris-HCl (pH 7.4) containing 5% glycerol, and His-tagged LipB was eluted by using a gradient of 0 to 250 mM ammonium sulfate in the same buffer. LplA was purified exactly as described previously (11). Lipoylation activity was measured by the pyruvate dehydrogenase activation and gel mobility shift assays described previously (7, 8). In the former assay, lipoylation is measured by conversion of the inactive apo form of pyruvate dehydrogenase to the active lipoylated form (7), whereas in the latter assay lipoylation or octanoylation is measured by shift of the electrophoretic mobility of a purified lipoyl domain derived from E. coli pyruvate dehydrogenase (6, 8). Upon acylation of the target lysine, the electrophoretic mobility of the lipoyl domain increases due to loss of the positively charged side chain.
Synthesis of lipol-adenylate. The lipoyl-AMP analogue, lipol-adenylate (LipOH-AMP) was made as follows. Lipoic acid was reduced to the alcohol (lipol) with 1.25 eq of BH3 in tetrahydrofuran (2). This reagent does not reduce disulfides (2). After hydrogen evolution was complete, 15 ml of a 1:1 mixture of water and tetrahydrofuran was added to decompose any remaining reducing agent. The solution was then saturated with potassium carbonate, and lipol was extracted with ethyl ether. The extracts were dried with sodium sulfate, and the solvent was removed by rotary evaporation to give a quantitative yield of product. The 5'-phosphate of 2',3'-O-isopropylidene adenosine was synthesized from 2',3'-O-isopropylidene adenosine and 2-cyanoethyl phosphate as described by Tenner (21) and purified on a column of DEAE-Sephadex A25 equilibrated in 5 mM ammonium bicarbonate. Any remaining 2',3'-O-isopropylidene adenosine was eluted with 5 mM ammonium bicarbonate, whereas 2',3'-O-isopropylidene adenosine-5'-phosphate was eluted with 0.2 M ammonium bicarbonate. This solution was taken to dryness by rotary evaporation, dissolved in water, and again evaporated to dryness in order to remove ammonium bicarbonate. The 2',3'-O-isopropylidene adenosine-5'-phosphate (2.66 mmol) was then converted to the pyridinium salt (1), which was mixed with a solution of 10 mmol of lipol in dry pyridine. To this mixture 10 mmol of the coupling reagent 1,3-dicyclohexylcarbodiimide was added, and the solution was then stirred for 40 h at room temperature (1). Water was added to decompose any remaining coupling reagent. The solution was filtered and the filtrate was taken to dryness by rotary evaporation. The residue was dissolved in water and again evaporated in order to remove residual pyridine. The residue was then taken up in 150 ml of 20% acetic acid and refluxed for 2 h to remove the isopropylidene protecting group (21). After it cooled, the solution was again filtered and evaporated to dryness. Thin-layer chromatography (silica gel 60) in 2-propanol-concentrated NH4OH-water (7/3/1, by volume) showed that the major contaminant was AMP. The mixture was then loaded on a DEAE-Sephadex A25 column equilibrated in 20 mM triethylammonium bicarbonate. LipOH-AMP was eluted with 0.2 M triethylammonium bicarbonate (AMP remained on the column) and evaporated to dryness. The product showed a UV absorption maximum at 259 nm for the adenine ring with a shoulder at 302 nm. The shoulder was attributed to the thiolane ring since it disappeared upon treatment with the disulfide reducing agent tris(2-carboxyethyl)phosphine. Electrospray mass spectroscopy gave a mass of 536.2 for the product versus the calculated value of 536.1 (ammonium salt).
|
|
|---|
The in vitro temperature stabilities of the lipoyltransferases of the mutant strains were tested by treating cell extracts at 55°C for various periods of time before being placed on ice. The extracts were then assayed for lipoyltransferase activity by the pyruvate dehydrogenase activation assay (Fig. 2). The lipoyltransferase activities of strains SWJ175, SWJ178, and SWJ181 (carrying plasmids pSJ65, pSJ68, and pKR111, respectively) had similar temperature stabilities, whereas that of strain SWJ177 (carrying plasmid pSJ67) had a severely decreased temperature stability (Fig. 2). Therefore, the temperature-sensitive lipB allele results in the production of a lipoyltransferase of increased thermal lability. These data demonstrate that lipB is the gene that encodes the lipoyl (octanoyl) transferase and precludes an indirect regulatory role for the protein in lipoate metabolism.
![]() View larger version (19K): [in a new window] |
FIG. 2. Thermolability of the lipoyltransferase activity of cell extracts. Cell extracts of the lipB strain KER184 carrying either plasmid pKR111, which expresses the wild-type lipB allele, or plasmid pSJ67, which expresses the temperature-sensitive lipB67 allele, were heated at 55°C for the time periods shown before being placed on ice. After all samples had been treated, the samples were assayed for lipoyltransferase activity by activation of apo-pyruvate dehydrogenase. Symbols: , activity of the wild-type lipB extract; , activity of the lipB67 mutant extract. Note the nonlinear time scale used early in the time course.
|
![]() View larger version (32K): [in a new window] |
FIG. 3. Alignments of LipB N termini. The amino acid sequences were those deduced from the DNA sequences rather than those deduced during annotation of the gene sequences. The methionine codon that was thought to be the initiation codon is marked with an arrow. The first amino acid residue is given is that normally encoded by that codon to illustrate the use of alternate initiation codons (TTG and GTG, which would be translated as methionine by the translation initiation complex). Residues conserved in at least seven of the eight sequences are given in boldface, and a conserved cluster of hydrophobic residues is given in italic boldface. Sequences: Ec, E. coli; At, Arabidopsis thaliania; St, Salmonella enterica serovar Typhi; Kp, Klebsiella pneumoniae; Bu, Buchnera sp. strain APS; Nm, Neisseria meningitidis; Vc, Vibrio cholerae; Xf, Xylella fastidiosa; Hs, Haemophilus somnus; Hi, Haemophilus influenzae.
|
29 kDa in the strain that expressed the longer protein encoded by plasmid pSJ120. This corresponded well to the expected 28.7-kDa mass of the longer His-tagged LipB fusion protein (Fig. 4A). The His-tagged version of the 191-residue protein encoded by pSJ122 gave no obvious band in the expected region of the gel (predicted size of 26.1 kDa) (Jordan and Cronan, unpublished). Therefore, the shorter protein was unstable even when an artificial N-terminal extension (the His tag) was added. However, plasmids (pSJ112 and pSJ118, respectively) that expressed either the 191-residue ORF or the 213-residue ORF both complemented lipB null mutants (Jordan and Cronan, unpublished). These results suggest that the additional residues of the 213-residue ORF are not critical for enzyme activity but are necessary for stability of the protein in vivo.
![]() View larger version (74K): [in a new window] |
FIG. 4. Purification of His-tagged LipB. (A) SDS-gel electrophoretic analysis of steps in the purification of His-tagged LipB on a column of immobilized nickel cheleate. Lane 1, the cell extract of an uninduced culture; lane 2, flowthrough (unbound) fraction from the column; lanes 3 to 6, fractions from elution of the column with 8 mM imidazole; lane 7, fraction eluted with 80 mM imidazole. (B) Further purification of LipB from the immobilized nickel cheleate column by chromatography on a Mono-Q column. "FT" denotes the flowthrough (unbound) fraction. The fractions containing the peak of lipoyltransferase activity are designated peak fractions. The numbers at the left are the molecular masses of the protein standards in kilodaltons, and the His-tagged LipB bands are indicated by arrows.
|
1,200-fold. The His-tagged LipB was purified directly from cell extracts by immobilized nickel-chelate column chromatography, followed by ion-exchange chromatography to obtain a homogeneous protein (Fig. 4). The purified LipB protein had high levels of lipoyltransferase activity in both assays. The gel mobility shift assay was used to test the ability of LipB to utilize octanoyl-ACP (Fig. 5) or lipoyl-ACP (data not shown) to modify the lipoyl domain. As expected from prior results with cell extracts (9), the purified His-tagged LipB converted the apo form of a lipoyl-domain to the holo domain by using either octanoyl-ACP or lipoyl-ACP. When LipB was tested for the ability to use ATP plus octanoic acid (Fig. 5) or lipoic acid (data not shown), no modification was detected. The ability of the purified LipB preparation to transfer lipoate from lipoyl-ACP to pyruvate dehydrogenase was determined by the activation of apo-pyruvate dehydrogenase. LipB was found to follow Michaelis-Menten kinetics (data not shown) with a Km for lipoyl-ACP of
1 µM (Table 1).
![]() View larger version (49K): [in a new window] |
FIG. 5. Gel shift assays of LplA and His-tagged LipB with octanoate plus ATP or octanoyl-ACP. Essentially identical results were obtained with lipoate plus ATP and lipoyl-ACP (data not shown). The assays were performed as described in Materials and Methods. In this assay the modified (M) form of the lipoyl domain protein migrates faster that the unmodified (U) form on these nondenaturing gels due to the increase in net negative charge that results from acylation of the target lysine residue. The substrates in lanes A to E were octanoic acid plus ATP, whereas the substrate in lanes F to L was octanoyl-ACP (C8-ACP), which is the fastest-migrating protein species. The ACP produced upon transfer of octanoate to the lipoyl domain gives a band of intermediate migration rate. Enzyme sources: 1ane A, 10 µg of cell extract protein from the lipB strain KER184; lane B, 1 pg of purified LplA; lane C, 10 pg of purified LplA; lane D, 1 ng of purified His-tagged LipB; lane E, 100 ng of purified His-tagged LipB; lane F, reaction lacking lipoyl domain protein; lane G, 10 µg of cell extract protein from the lipB strain KER184; lane H, 10 pg of purified LplA; lane I, 1 ng of purified LplA; lane J, 1 pg of purified His-tagged LipB; lane K, 1 pg of purified His-tagged LipB (but the reaction lacked octanoyl-ACP); lane L, reaction lacking enzyme.
|
|
View this table: [in a new window] |
TABLE 1. Kinetic constants of LipB and LplA
|
In order to test whether LplA possessed lipoyltransferase activity, we tested the ability of purified LplA to use octanoyl-ACP and lipoyl-ACP as substrates in vitro. We used the gel mobility shift assay to assess the ability of LplA to use octanoyl-ACP as a substrate in place of free octanoic acid plus ATP (Fig. 5). LplA did indeed use octanoyl-ACP as a substrate, although extremely inefficiently. The octanoyl-ACP reaction required ca. 100-fold more enzyme than was required for comparable activity with the ligase substrates, octanoic acid plus ATP. LplA also used lipoyl-ACP as a substrate, as detected by the both the gel mobility shift (data not shown) and pyruvate dehydrogenase activation assays. The latter assay gave a Km of
9 µM for the reaction of LplA with lipoyl-ACP (Table 1). Since the activity observed with ACP-bound substrates required high levels of LplA, it seemed possible that activities observed with octanoyl-ACP and lipoyl-ACP as substrates were due to LipB contamination of our LplA preparation. To test this possibility, we purified LplA that was overproduced in a lipB-null mutant strain and obtained an enzyme preparation that had the same activity on the ACP-bound substrates as the preparations from a wild-type host strain (data not shown). In another test we synthesized a nonhydrolyzable lipoyl-AMP analogue, lipol-AMP (Fig. 6), that, based on the corresponding aminoacyl-AMP analogues (13, 18), was expected to inhibit the reaction with free lipoic acid (plus ATP) catalyzed by LplA by occupying the active site. Indeed, lipol-AMP was found to be a competitive inhibitor of the reaction, although the analogue was a rather impotent inhibitor (Fig. 7A), suggesting that the lipoate carboxyl group plays an important role in lipoyl-AMP binding. We expected that, if the two reactions catalyzed by LplA used the same active site, then lipol-AMP should also inhibit transfer of lipoate from lipoyl-ACP to apo-pyruvate dehydrogenase. Indeed, the analogue also competitively inhibited the lipoyl-ACP reaction, indicating that both reactions were catalyzed by the same active site (Fig. 7B). Therefore, we conclude that a low level of transferase activity with ACP thioester donors is an intrinsic property of LplA. It should be noted that parallel experiments with purified LipB and lipoyl-ACP showed no inhibition of the LipB-catalyzed lipoate transfer reaction (data not shown).
![]() View larger version (17K): [in a new window] |
FIG. 6. Structures of lipoyl-AMP and the reduced analogue. (A) Lipoyl-AMP (lipoyl-adenylate). (B) Reduced analog, lipol-AMP (lipol-adenylate). The two compounds differ in the linkage of the lipoyl moiety to the phosphate of AMP. In lipoyl-AMP the linkage is a mixed anhydride, whereas the anhydride linkage is replaced with an ester in lipol-AMP.
|
![]() View larger version (17K): [in a new window] |
FIG. 7. Inhibition of LplA by lipol-AMP. (A) LplA-catalyzed transfer of lipoic acid from lipoyl-ACP to apo-pyruvate dehydrogenase. (B) LplA-catalyzed ATP-dependent attachment of lipoic acid to apo-pyruvate dehydrogenase. The small graphs to the right of the panels are magnifications of the regions close to the axis so that the competitive inhibition character can be more readily seen. The inhibitor was added at 1 mM. The velocity (V) values are apo-pyruvate dehydrogenase activation units (see Table 1), and the substrate concentrations are given in micromolar amounts. The inhibition constant (Ki) for the lipoic acid plus ATP reaction was 370 µM, whereas the Ki for the lipoyl-ACP reaction was 666 µM. Lipol-AMP (1 mM) had no detectable effect on the rate of LipB-catalyzed transfer of lipoic acid from lipoyl-ACP to apo-pyruvate dehydrogenase over a range of substrate concentrations. Symbols: , reactions in the presence of 1 mM lipol-AMP; and , reactions lacking inhibitor.
|
|
|
|---|
This genetic evidence caused us to return to the problematical expression of the LipB protein. Sequence alignments with data available from the many genome sequences completed since our original work suggested that we had chosen the wrong initiation codon for E. coli lipB. Since a very highly conserved methionine codon is present in the analogous location in most other lipB genes, the annotators of the E. coli genome sequence (and those of most other genome sequences) had also designated this codon as the initiation codon. However, use of an upstream TTG (leucine) codon gave a stable and functional protein, and thus our prior inability to effectively overproduce LipB was due to degradation of the truncated protein. Vaisvila et al. (22) independently found that only the 213-residue LipB protein was stable upon overproduction (enzyme activity was not measured). The use of alternate initiation codons such as TTG and GTG generally results in lower expression than an ATG codon (20). Indeed, lipB is expressed at very low levels in vivo (17), a finding consistent with the use of a poor initiation codon. Consistent with these data, we purified the lipoyltransferase activity by more than 50,00-fold from extracts of wild-type cells by a combination of conventional and affinity chromatographic steps with retention of about half of the original activity but were unable to detect a protein band corresponding to the enzyme (Jordan and Cronan, unpublished). Given the final yield of protein, the molecular weight of LipB, and the mass of the cells extracted, we calculate that LipB is present at a level of <10 molecules per wild-type cell. It is noteworthy that very low levels of protein expression seems characteristic of the E. coli enzymes that perform rare protein modifications such as lipoylation (lipB and lplA), biotinylation (birA), and phosphopantetheinylation (acpS). Starting with extracts of wild-type cells, each of these enzymes required a purification of several tens of thousands-fold to detect the protein by gel electrophoresis, and the final preparations were often not homogeneous (5, 6, 9). Moreover, each of the genes encoding the enzymes has a low codon adaptation index (19), a property of E. coli genes expressed at low to very low levels that indicates frequent use of nonabundant tRNA species in decoding the mRNAs. The values for E. coli lipB, lplA, birA, and acpS are 0.269, 0.330, 0.257, and 0.293, respectively, whereas LacI, which is present at 5 to 10 copies/cell (14), has an index of 0.296 and highly expressed proteins have indices of >0.8 (19).
Although the mechanism by which LipB functions in vivo is not yet fully understood, our work demonstrates that lipB is indeed the structural gene for the lipoyl (octanoyl) transferase. This enzyme uses the presumed product of lipoic acid biosynthesis, lipoyl-ACP, as a substrate, but it can also use octanoyl-ACP. Probably the most interesting aspect of the enzyme study was the finding that LplA utilizes either lipoyl-ACP or free lipoic acid plus ATP as substrates for lipoylation of apo-pyruvate dehydrogenase (the octanoate species are also active). This is a curious and unexpected result since the linkages attacked by the lipoyl domain lysine
-amino group differ in the two enzymes. The nucleophilic amino group attacks a mixed anhydride when lipoyl-AMP is the substrate, but it attacks a thioester when lipoyl-ACP is the substrate. How can the LplA active site cope with such different chemistries? One possibility is that LplA protein becomes lipoylated on an active site residue such as a cysteine, serine, or histidine, and it is this linkage that undergoes nucleophilic attack by the lysine amino group. If so, the slow reaction of LplA with lipoyl-ACP could be due to attack of the putative active site residue on the thioester linkage to form the same enzyme-bound intermediate formed from lipoyl-AMP. (Note that the ACP protein moiety need not sterically hinder this interaction since the lipoyl moiety is linked to the protein by the extended phosphopanthetheine prosthetic group of ACP.) Analogous chemical acylations of active site residues are known for the 3-ketoacyl-ACP synthases and malonyl-CoA:ACP transacylases involved in the elongation steps of fatty acid synthesis (3). If this scenario applies, then lipoyl-ACP could be acting as a model substrate of LplA presumably due to binding of the lipoyl moiety by the enzyme active site. This model reaction would be very inefficient (as we have observed) and thus would be physiologically useful only upon high levels of LplA overexpression (12). We are currently studying the reaction mechanisms of LipB and LplA.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»